510(k) K893755
K893755 is an FDA 510(k) premarket notification submitted by Biokit USA, Inc. for the device "RUBAGEN". The FDA issued a decision of Substantially Equivalent on August 21, 1989. The device falls under product code LQN (Latex Agglutination Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Biokit USA, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 21, 1989
- Date Received
- May 19, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Latex Agglutination Assay, Rubella
- Device Class
- Class II
- Regulation Number
- 866.3510
- Review Panel
- MI
- Submission Type